SYNDAX PHARMACEUTICALS INC shareholders Q3 2023

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

SYNDAX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,600,000$52,272,0008.55%
Foresite Capital Management IV, LLC 875,000$12,705,0007.06%
Aisling Capital Management LP 1,025,000$14,883,0006.13%
Saturn V Capital Management LP 807,969$11,731,7104.91%
Eversept Partners, LP 2,596,245$37,697,4773.19%
ACUTA CAPITAL PARTNERS, LLC 297,035$4,312,9482.89%
Paradigm Biocapital Advisors LP 2,390,077$34,703,9182.36%
DAFNA Capital Management LLC 458,373$6,655,5762.07%
SPHERA FUNDS MANAGEMENT LTD. 773,061$11,224,8462.04%
PFM Health Sciences, LP 2,715,235$39,425,2121.86%
Avidity Partners Management LP 2,821,000$40,960,9201.65%
COMMODORE CAPITAL LP 957,509$13,903,0311.62%
Ghost Tree Capital, LLC 300,000$4,356,0001.43%
Ikarian Capital, LLC 7,500$10,890,0001.31%
Yelin Lapidot Holdings Management Ltd. 114,530$1,662,9760.99%
Ghost Tree Capital, LLC 200,000$2,904,0000.96%
Kynam Capital Management, LP 400,000$5,808,0000.95%
Sofinnova Investments, Inc. 941,817$13,675,1830.86%
Mesirow Financial Investment Management, Inc. 12,283$178,3490.78%
Palo Alto Investors LP 472,600$6,862,1520.65%
External links

This page lists SYNDAX PHARMACEUTICALS INC's shareholders in Q3 2023. To view SYNDAX PHARMACEUTICALS INC's shareholder history, click here.